Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Aldeyra Therapeutics Inc’s stock clocked out at $2.15, down -5.70% from its previous closing price of $2.28. In other words, the price has decreased by -$5.70 from its previous closing price. On the day, 1.28 million shares were traded.
Ratios:
To gain a deeper understanding of ALDX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.39 and its Current Ratio is at 6.39. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.24.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 03 ’25 when PERCEPTIVE ADVISORS LLC sold 3,400,000 shares for $1.42 per share. The transaction valued at 4,828,000 led to the insider holds 5,875,851 shares of the business.
Machatha Stephen sold 16,041 shares of ALDX for $75,975 on Aug 12 ’24. The Chief Development Officer now owns 236,771 shares after completing the transaction at $4.74 per share. On Aug 12 ’24, another insider, Greenberg Bruce, who serves as the insider of the company, sold 10,834 shares for $4.74 each. As a result, the insider received 51,313 and left with 126,382 shares of the company.
Stock Price History:
Over the past 52 weeks, ALDX has reached a high of $7.20, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is -29.28%, while the 200-Day Moving Average is calculated to be -55.87%.
Shares Statistics:
A total of 60.05M shares are outstanding, with a floating share count of 58.15M. Insiders hold about 2.92% of the company’s shares, while institutions hold 56.18% stake in the company.
